Login to Your Account



Enhancing demographic trial data not easier said than done

By Mari Serebrov
Regulatory Editor

Monday, February 29, 2016

In labs all around the world, big data have researchers "acting like kids in a candy store," the NIH's Charles Rotimi said at an FDA meeting on enhancing demographic subgroup data for drugs, biologics and devices.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription